Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...
Late-Breaking Science Abstract LB 032 - In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days starting ...
In a phase III clinical trial in China, stroke patients treated intravenously with loberamisal, a novel neuroprotective ...
Rehabilitation from stroke has traditionally focused on improving the function of the most severely affected arm. But ...
Stroke survivors often face long-term challenges with arm function, but new research suggests that training the less-affected ...
Phagenesis, a commercial-stage company with a first-of-its-kind neuromodulation system to treat patients experiencing difficulty swallowing post-stroke, welcomed the 2026 Guideline for the Early ...
Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, ...
A stroke occurs when the flow of oxygen-carrying blood to part of the brain is interrupted by a blockage in a blood vessel or ...
A smartwatch app designed to measure social interactions of hospitalized stroke survivors may enable new treatments to ...
UC experts present stroke research at the International Stroke Conference 2026, discussing post-stroke disability predictors ...
People are understandably concerned when health conditions or infectious diseases that were once well-managed start increasing again, but proper education and advancements in medicine mean we often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results